Tumor cells can escape inhibition of androgen synthesis by goserelin or abiraterone by increasing, intratumorally, androgen synthesis and/or AR, but also via glucocorticoid receptors and glucocorticoids [188]. This evidence concerns the gene AR and neoplasm.